This study identified putative pathogenic variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2 as the most prominent genes for breast cancer, harboring protein-truncating variants that confer significant disease risks (odds ratio of 2.10 to 10.57) to overall breast cancer risk. This evidence concerns the gene BRCA2 and breast carcinoma.